Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
COO compared with WST: revenue, margins and what each company keeps, and the suppliers and customers both name
COO
Cooper Companies, Inc.
Change
Mkt cap
Revenue
Revenue
WST
West Pharmaceutical Services Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
COO
Cooper Companies, Inc.
vs
WST
West Pharmaceutical Services Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
COO
2 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±9.6%
▼
−14.67%
×1.53
Q2 FY26
±8.4%
▲
+8.58%
×1.02
Q1 FY26
±8.3%
▼
−4.55%
×0.54
Dec 5 '25
±9.0%
▲
+5.67%
×0.63
WST
1 of 4
at or beyond implied
Report
implied
realized
× implied
Oct 29 '26
±8.3%
▲
+3.23%
×0.39
Q2 FY26
±8.9%
▼
−0.82%
×0.09
= implied
COO realized, solid
WST realized, hatched
One scale, both sides: full bar = 15%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±10.2%
▲
+12.86%
×1.26
Feb 12 '26
±10.2%
▼
−1.04%
×0.10
COO
Cooper Companies, Inc.
Change
63.47
▼
−1.48%
· post 63.47
Mkt cap
$12.2B
Revenue
$1.1B
Q3 FY26
Revenue
$4.1B
FY25
WST
West Pharmaceutical Services Inc
Change
393.18
▼
−3.82%
· post 389.31
Closed
Nov 5 '26
Mkt cap
$28.8B
Revenue
$872M
Q2 FY26
Revenue
$3.1B
FY25
vs
Compare
Closed
Nov 5 '26
COO
Cooper Companies, Inc.
vs
WST
West Pharmaceutical Services Inc
63.47
▼
−1.48%
post 63.47
Price
393.18
▼
−3.82%
post 389.31
$12.2B
Mkt cap
$28.8B
Q3 FY26
$1.1B
Revenue
$872M
Q2 FY26
FY25
$4.1B
Revenue
$3.1B
FY25
Change
Change
COO
63.47
▼
−1.48%
vs
WST
393.18
▼
−3.82%
Closed
Nov 5 '26